chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash under her right arm were the booster was administered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash under her right arm were the booster was administered) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027h21b, 009c21a and 002c21a) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included BENAZEPRIL for an unknown indication.   On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced VACCINATION SITE RASH (rash under her right arm were the booster was administered). The patient was treated with HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (rash under her right arm were the booster was administered) had not resolved.            Concomitant products included hypertension medication.   This case was linked to MOD-2021-428466 (Patient Link).
Client received first dose of COVID vaccine @ 2:25pm, complained of feeling dizzy, tunnel vision, and feeling like "passing out".  Client placed in zero-gravity chair, given water to drink.  Vital signs stable, continued observation until symptoms improved.  Client made aware to follow up with his primary care.  Client walked out of observation area with steady gait @ 3:36 pm, friend to drive him home.
Patient developed Bell palsy on left side of face. No other apparent etiology or treatment - illness.
LIGHT HEADED AND TINGLING EXTREMITIES POST VACCINATION   BP 138/94mmHg  O2 SAT 98%  HR 87 BPM  TREATMENT 16 fl oz WATER
patient experienced multiple syncope episodes after her second dose of the pfizer vaccine, she mentioned she was pretty anxious before the vaccine.
Moderna COVID-19 Vaccine EUA  About 3-5 minutes after receiving the shot, the right side of my face and throat became numb. Then I felt a burning sensation in my chest for about 30 seconds to a minute. After about an hour to an hour and a half the numbness went away. I then felt very tired /lethargic. 7 hours after the shot, I started feeling better/more normal.
Patient noted sudden onset this morning (1/14/21 at 8:30am) of full body flat, red itchy rash. Patient called in, will take benadryl.
Patient was given the monovalent vaccine vs the bivalent. no known adverse outcome. We were told DPH to record this as a med error.
slight runny nose; feel little down for about 3 or 4 days; not feeling good; head ache; chills; 99.1°F fever; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (slight runny nose), DEPRESSED MOOD (feel little down for about 3 or 4 days), FEELING ABNORMAL (not feeling good), HEADACHE (head ache) and CHILLS (chills) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004621A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (slight runny nose), DEPRESSED MOOD (feel little down for about 3 or 4 days), FEELING ABNORMAL (not feeling good), HEADACHE (head ache), CHILLS (chills) and PYREXIA (99.1°F fever). At the time of the report, RHINORRHOEA (slight runny nose), DEPRESSED MOOD (feel little down for about 3 or 4 days), FEELING ABNORMAL (not feeling good), HEADACHE (head ache), CHILLS (chills) and PYREXIA (99.1°F fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.1 (High) 99.1°F fever.  No relevant concomitant medications were reported.  No treatment information was provided.
I have common cold symptoms. I had stuffy nose, cough, headache, and a low-grade fever.  I had server fatigue. I contacted my doctor.  I went to hospital to get the antibody fusion on Saturday. I had positive covid-19 test of last week.
This spontaneous report as received from a registered nurse refers to a 19 year old patient. The patient's pertinent medical history, drug reaction or allergies and concomitant therapies were not reported. On 09-MAR-2018, the patient was inadvertently vaccinated with a pediatric dose of VAQTA for prophylaxis). Dosing details, lot # and expiry date were not reported. No adverse effects were reported. Product quality complaint (PQC) was not involved.
breakthrough of COVID after being vaccinated; breakthrough of COVID after being vaccinated; Rheumatoid arthritis flare up; Pain; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4407148-00 (AbbVie).  A 71-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation; adalimumab (HUMIRA), since 01Jan2020 (ongoing) (Lot number: 1153557), subcutaneous for rheumatoid arthritis. The patient's relevant medical history was not reported. Concomitant medication(s) included: METHOTREXATE. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "not recovered", COVID-19 (medically significant), outcome "recovered" and all described as "breakthrough of COVID after being vaccinated"; RHEUMATOID ARTHRITIS (medically significant), outcome "not recovered", described as "Rheumatoid arthritis flare up"; PAIN (non-serious), outcome "recovered". It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The action taken for adalimumab was dosage not changed.  The reporter's assessment of the causal relationship of "breakthrough of covid after being vaccinated", "rheumatoid arthritis flare up" and "pain" with the suspect product(s) BNT162b2 was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  The reporter's causality for the event(s) of pain with HUMIRA(Adalimumab) was no reasonable possibility. The reporter's causality for the event(s) of breakthrough of covid after being vaccinated and rheumatoid arthritis flare ups was not provided."  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the reported events  and suspect drug BNT162B2 cannot be excluded.
sore arm; This is a spontaneous report from a contactable other health care professional. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 03Mar2021 as DOSE 2, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. Historical vaccine included: first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection.) as dose 1, single on 10Feb2021 for COVID-19 immunization. Patient was healthy and had not been COVID positive. Patient would like to join a trial for booster doses of these vaccines. On 03Mar2021, the patient experienced sore arm. The outcome of the event was recovered on 04Mar2021.   The lot number was not provided. Information on lot number has been requested during follow up.
Swollen eyes; Eye pain with discharge; Eye pain with discharge; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Apr2021 at 16:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included severe allergies, anaphylactic, asthma, COVID-19 and allergies to tree nuts, bees. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication was not reported. The patient previously took codeine (MANUFACTURER UNKNOWN), LEVAQUIN and experienced drug allergy. On 29Apr2021 at 18:00, the patient experienced swollen eyes, and eye pain with discharge. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of swollen eyes, and eye pain with discharge were ongoing at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Rash that was diagnosed as Guttate Psoriasis, but usually appears in children/young adults, appears after a bacterial infection such as Strep and usually there is a family history of it, none of which pertain to me.
I received the vaccine as 1 shot to my left arm. I felt fine until about 530pm and then I started getting body aches, head aches, and severe chills. I could not sleep at all throughout the night my body was extremely temperature sensitive. I was hot and then cold, hot and then cold. The symptoms went away after 24 hours and now I'm fine. It was a horrible night of discomfort and pain.
Pt. left arm was red, swollen and warm touch, but never ran a fever. Pt. was put on Cephalexin 10.5.17.
Information has been received from a health professional concerning a 16 year old female patient who on 22-JUN-2007 was vaccinated IM with a first dose of Gardasil lot #654535/0960F. The patient while sitting passed out for one minute. She appeared fine and an electrocardiogram and blood pressure were normal. She was observed in the office for an hour. No additional information at this time. The patient recovered. Additional information has been requested.
This spontaneous report was received from an approximately 59 year old female patient regarding herself. There was no pertinent medical history and no drug reactions/allergies. Approximately on 17-OCT-2013 (reproted as about 3 weeks ago), the patient was vaccinated with 0.65 milliliter (ml) (reported as standard dose) of ZOSTAVAX (lot number and expiry date unspecified), subcutaneously . Other suspect therapy included influenza virus vaccine (manufacturer unknown) (lot number, expiry date, dose and route unspecified) administered approximately on 17-OCT-2013 (reported as on the date of ZOSTAVAX vaccination). No concomitant therapy was reported. Approximately on 20-OCT-2013 (reported as 3-4 days later), after the vaccination, the patient developed shingles outbreak. Approximately on 20-OCT-2013 (reported as 3-4 days later), she developed the conditions on her forehead and in her hair. The patient sought medical attention (called the physician's office). The patient had received an unspecified treatment for the conditions. No lab tests were performed. The patient was recovering at the time of report. The relatedness for shingles outbreak was unknown for ZOSTAVAX and influenza virus vaccine (manufacturer unknown). Additional information has been requested.
Pt had to go into ER 1 day after the vaccine and claimed to be diagnosed of GBS (Guillain Barre Syndrome).
Patient with sore arm day of event.  Next day began to have some blinking of right eye, on medial side, which persisted for next two days.  On 1/25/2021 began to have some numbness of right side of face starting on temple/ forehead, then beginning to extend down towards chin, before coming around the left side of face and becoming completely circumferential.  Patient states felt leathery to the touch at that time due to decreased sensation.  No facial asymmetry or weakness to muscles of facial expression noted by patient at any time. Patient went to sleep that night, fully resolved on waking in the AM.
pt felt light head and dizzy, then fell from seat. pt laid on floor for a few minutes before getting up, sitting for a few more minutes then leaving facility
Rash, hive like bumps, on right side of the trunk under ribs, progressing to left side over the day and round to the back resolved with application of hydrocrtisone cream.
IT STARTED WITH A LiTE HEAD ACHE (I DO NOT GET HEAD ACHES) FOR A FEW DAYS, THEN PAIN IN MY SHOULDERS AND NECK, DiZZY, LOSS OF BALANCE AND APPiTiTE, COULDN'T SLEEP BECAUSE OF PAIN, PAIN IN MY WHOLE UPPER BODY. IT LAST OVER 2 WEEKS. MY SON TOOK ME TO THE HOSPITAL EMG. 9-30-20 10:56 AM. (HE LOST 2 DAYS OFF WORK.) IT WAS PAINFUL TO JUST MOVE ANY PART OF MY BODY. IT'S STILL PAINFUL TO BEND MY HEAD BACK. 10-27-20 "IF" I GET A FLU SHOT NEXT YEAR, IT WON'T BE THIS ONE!
Ten minutes after injection patient complained of severe itching.  Dime sized redness noted at injection site.  Patient was provided with an ice pack and instructed to use some Benadryl.
sick; exhausted; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness and exhaustion. On an unknown date, the outcome of the sickness was unknown and the outcome of the exhaustion was recovered/resolved.   It was unknown if the reporter considered the sickness and exhaustion to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 16-JUN-2022 Reporter's Comments: This case was received from patient via interactive digital media. The patient was sick since he/she got the first shot, scared to death of the second shot. The patient had a bad reaction to the first shot, exhausted for over 4 days. Additional Supportive Information: The follow-up would not possible as no contact details were available.
I had the full 2-vaccine, booster and bivalent booster series for Covid-19 between 1/29/2021 and 10/2/2022, with no or minor side effects. Two months after my fourth shot, I was diagnosed with lymphoma on 12/5/2022, and am currently undergoing chemotherapy treatment. (I don't see how these could be possibly be related.)
Fever, shaking chills, body aches, nausea, weakness, dizziness
On 3/26/2023, I had fatigue, muscle aches, fever, cough, headache, and wheezing. I took a rapid antigen test and got a negative result. I took two Advil, which helped. On 3/27/2023, I felt worse. The aforementioned symptoms worsened, and my temperature was 101. I took another home antigen test and got a positive result. I called my doctor's office to ask about getting Paxlovid, and I was given a telehealth appointment for the next day with them to see if I was a candidate for the medication. On 3/28/2023, I had the telehealth appointment and was prescribed Paxlovid, which I began taking that day. My symptoms were more severe that day. My blood oxygen saturation level was 92 or 93, and my temperature was 102. I continued to also have the aforementioned symptoms of fatigue, muscle aches, coughing, and wheezing. I alternated between Tylenol and Advil to treat my symptoms, and they were pretty effective in relieving my fever and headache. I had to use my albuterol inhaler on account of the wheezing. I then developed massive diarrhea, which I think may have been caused by the Paxlovid. On 3/29/2023, I had taken four doses of Paxlovid. I passed out that night and hit my head on the floor. I don't know how long I was out, but I woke up on the floor. I felt really dizzy and ill. On 3/30/2023, I called my doctor's office and told them about the incident, and I was advised to cease taking the Paxlovid. My diarrhea probably got better by the end of the day. My temperature was also down to about 100.5 that day. My oxygen saturation was still about 93 or 94. By 3/31/2023, I was afebrile, but I still had headaches and extreme fatigue. At the time of this writing, I continue to have a productive cough and extreme fatigue, and I am still afebrile. I no longer have a headache or muscle aches. Today my oxygen saturation level is 96.
I had little bit of cold, congestion, mild on Monday night. Tuesday I started getting a fever and started getting a fever. I was running 99.5 which is high for me because I usually run 97.5. Wed/Thurs I had fatigue, congestion, sore throat. I still have residual snotty nose as of today, not really runny, just green build up in my nose. This is not normal for me. Friday I wasn't feeling better and fever was up to 100. I contacted my health provider. I got Paxlovid on Friday and my fever broke Friday night.
Information has been received from a health professional concerning an approximately 27 year old female registered nurse, with a tissue plasminogen activator (TPA) deficiency, who in 1990, was vaccinated with a single dose of hep B virus vaccine rHBsAg (yeast). Concomitant therapy included warfarin sodium (Coumadin). Subsequently the pt developed malaise and muscle aches. It was reported that the pt recovered. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow up information from the RN indication that she received an injection and was sick with extreme weakness, nausea and vomiting for the next 4 days. She noted that she could not get out of bed with feeling light headed and severe muscle aches. It was also noted that she did not receive another injection. Additional information is not expected. Additional follow up information from an approximately 27 year old female registered niurse with a morphine allergy indicated that her flu-like symptoms which included having been bed ridden for 4 days, faintness, extreme weakness and body aches had developed within 24 hours of her first dose of HEPATITIS B. Subsequently the patient recovered. These events were not reported to the physician.
Night of injection, arm soreness, chills and fever of 101.6. Afebrile currently but has headache.
Lip swelling 4-6 hours after. no stridor, angioedema, or fever continued for 36 hours and has improved
Patient was given vaccine by an extern student. Parent did no call to report any symptoms or complications after vaccination.
32-year-old female with a history of GERD, obesity who presents the emergency department with a 4-day history of gradual onset symptoms beginning with nasal congestion sore throat followed by nonproductive cough.  Patient denies subjective fevers or chills however was told by her employer to come to the emergency department for Covid testing.  Patient reports that she got her second COVID-19 mRNA vaccination in February 2021.  Patient denies COVID-19 or other sick contacts.  Patient denies shortness of breath.  Patient has been using over-the-counter loratadine with minimal improvement.  Patient reports over the past 24 hours she developed some loose stools however denies any recent travel or other sick contacts no new foods.  Patient denies pain other than mild burning chest discomfort with cough which she rates as a 1 out of 10 on 10 point scale it is intermittent does not radiate.  10 point review systems otherwise negative.  Abbott nasal swab came back positive on 5/27/21.
itching (benadryl did not relive) strange dark rash/bruising or lesions on left side of body- including lower extremity.  Painful.
Patient was nervous prior to administration. Patient seemed fine after vaccination. Patient stood up and began walking and fainted. Father caught patient prior to lying her on the ground. She regained consciousness within seconds. Patient lay on ground until she felt ok (4 minutes) then sat in chair. Paramedic arrived to evaluate patient. No adverse events were found. Patient left with parents.
Pt did not have an adverse reaction. This is an administration error.   Pt was scheduled to recieve covod 19 vaccine. our office only has 5-11 vaccines available. Pt is 15 and recieved the wrong dosage for his age.  Pt also had already recieved 2nd dose of covid vaccine and our staff administered another dose. Pt has 3 covid vaccines.
15 min after vaccine administered patient stated she had a frontal headache radiating to her right side of head and tinglinig around her lips. She was instructed to stay for an additional 15 min for observation. She was placed on a stretcher to lie down.  She was conversing and her S/S went unchanged. At approx 1 pm she became unresponsive, she did not wake with touch or verbal command Her eyelids were fluttering as if she was experiencing a seizure. A condition was called. Pulse ox 100 % blood sugar 90. Monitor NSR. She remained unresponsive and was taken to the ED.  Upon arrival to the ED at approx 1:17 pm,  the ED nurse stated she was awake. Evaluated by physician, labs and CT head ordered. Patient stated all lab work and CT scan was normal. Employee was discharged with a diagnosis of vasovagal near syncope.
This spontaneous report was received from a nurse practitioner via a company representative, and refers to a male patient of unknown age. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, frequency, route, lot # and expiration date were not reported). No concomitant medications were reported. On 03-FEB-2016, the patient experienced a varicella like rash after being vaccinated with ZOSTAVAX. The patient sought medical attention through an unspecified contact. No intervention to prevent serious criteria was requested. No product quality complaint was involved. At the time of the report, the outcome of varicella like rash was unknown. The relatedness between varicella like rash and the ZOSTAVAX was not provided. Additional information has been requested.
Initial report received from a health care professional on 06 January 2011. A 35-year-old female patient received on 26 November 2010 an intramuscular injection (site not reported) of ADACEL, lot number not reported. The patient's medical history, adverse events from prior vaccination and concomitant medications were reported as unknown. The patient was having a post partum period at the time of vaccination with ADACEL. About one month after the vaccination of ADACEL, the patient developed numbness, at the injection site, arm pain and soreness and headache. The patient's blood pressure was also elevated. An abscess formed approximately the size of a tennis ball which ruptured and leaked. The patient was seen the Emergency Room (ER) where the drainage from the abscess was cultured and showed no growth. The diagnosis was made of sterile abscess. The patient reported some improvement. The outcome was reported as not recovered. Documents held by sender: None.
Drooping in the face (face paralysis), swelling around the spinal and cranial nerves, vision altered, headaches, prescribed steroids by healthcare professional.
LARGE RED SWOLLEN ITCHY HOT AREA AT INJECTION SITE. STARTED VERY SMALL BUT GETTING LARGER BY THE HOUR. TODAY IS FIRST DAY OF THE REACTION.  IT IS THE 9TH DAY AFTER THE DAY OF THE INJECTION.